Is HUMDF or VYM a better dividend investment in 2026?

HUMDF currently yields 484.14% with a 5% 5-year dividend growth rate. VYM yields 2.41% with 7.8% growth. The better choice depends on your goal: HUMDF offers higher current income.

What is the dividend yield difference between HUMDF and VYM?

HUMDF has a forward dividend yield of 484.14% ($2.00/share annually). VYM yields 2.41% ($3.51/share annually). The yield gap is 481.73 percentage points.

Home › Compare › HUMDF vs VYM

HUMDF vs VYM: Dividend Comparison 2026

HUMDF yields 484.14% · VYM yields 2.41%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HUMDF wins by $47899.98M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HUMDF

● Live price

484.14%

Share price

$0.41

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47900.01M

Annual income

$34,060,653,223.60

Full HUMDF calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.41%

Share price

$145.48

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$278.55

Full VYM calculator →

Portfolio growth — HUMDF vs VYM

📍 HUMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HUMDF	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HUMDF + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HUMDF pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUMDF

Annual income on $10K today (after 15% tax)

$41,152.26/yr

After 10yr DRIP, annual income (after tax)

$28,951,555,240.06/yr

VYM

Annual income on $10K today (after 15% tax)

$205.23/yr

After 10yr DRIP, annual income (after tax)

$236.77/yr

At 15% tax rate, HUMDF beats the other by $28,951,555,003.29/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUMDF + VYM for your $10,000?

HUMDF: 50%VYM: 50%

100% VYM50/50100% HUMDF

Portfolio after 10yr

$23950.02M

Annual income

$17,030,326,751.07/yr

Blended yield

71.11%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUMDF buys

VYM buys

Politician	Chamber	Ticker	Type	Amount	Date
Carol Devine Miller	🏢 House	$VYM	▲ Buy	$15,001 - $50,000	2022-11-02

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHUMDFVYM

Forward yield	484.14% ✓	2.41%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$47900.01M ✓	$27.8K
Annual income after 10y	$34,060,653,223.60 ✓	$278.55
Total dividends collected	$46687.76M ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HUMDF vs VYM ($10,000, DRIP)

Year	HUMDF Portfolio	HUMDF Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$59,114	$48,414.43	$11,151	$241.44	+$48.0K → HUMDF
2	$330,728	$267,475.81	$12,413	$246.79	+$318.3K → HUMDF
3	$1,752,431	$1,398,551.73	$13,794	$251.79	+$1.74M → HUMDF
4	$8,800,812	$6,925,711.29	$15,306	$256.47	+$8.79M → HUMDF
5	$41,922,789	$32,505,919.38	$16,960	$260.84	+$41.91M → HUMDF
6	$189,569,894	$144,712,509.91	$18,768	$264.92	+$189.55M → HUMDF
7	$814,403,207	$611,563,420.90	$20,745	$268.71	+$814.38M → HUMDF
8	$3,326,842,984	$2,455,431,552.18	$22,905	$272.24	+$3326.82M → HUMDF
9	$12,933,979,587	$9,374,257,594.32	$25,265	$275.51	+$12933.95M → HUMDF
10	$47,900,011,382	$34,060,653,223.60	$27,842	$278.55	+$47899.98M → HUMDF

HUMDF vs VYM: Complete Analysis 2026

HUMDF — Stock

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorporated in 2011 and is based in Beijing, China.

Full HUMDF Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this HUMDF vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUMDF vs SCHD HUMDF vs JEPI HUMDF vs O HUMDF vs KO HUMDF vs MAIN HUMDF vs VIG HUMDF vs DGRO HUMDF vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.